Chronic obstructive pulmonary disease (COPD) is currently the third leading mortality cause in the world. There is neither a reliable blood biomarkers to confirm its diagnosis nor curative treatment. In this study we tested the hypothesis that the lung function and cerebrovascular responsiveness for COPD patients may be altered by a novel therapy through restoration of ANS homeostasis along with the improvement of clinical symptoms.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords